These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28689651)

  • 1. Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine.
    Goldeck D; Theeten H; Hassouneh F; Oettinger L; Wistuba-Hamprecht K; Cools N; Tsitsilonis OE; Pawelec G
    Vaccine; 2017 Aug; 35(34):4330-4338. PubMed ID: 28689651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly.
    Akmatov MK; Riese P; Trittel S; May M; Prokein J; Illig T; Schindler C; Guzmán CA; Pessler F
    BMC Infect Dis; 2019 Jul; 19(1):656. PubMed ID: 31337344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.
    van den Berg SPH; Wong A; Hendriks M; Jacobi RHJ; van Baarle D; van Beek J
    Front Immunol; 2018; 9():82. PubMed ID: 29434600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination.
    Derhovanessian E; Theeten H; Hähnel K; Van Damme P; Cools N; Pawelec G
    Vaccine; 2013 Jan; 31(4):685-90. PubMed ID: 23196209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
    Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
    PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
    Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
    Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
    J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio.
    Strindhall J; Ernerudh J; Mörner A; Waalen K; Löfgren S; Matussek A; Bengner M
    Infect Dis (Lond); 2016; 48(6):436-42. PubMed ID: 27030916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination.
    Dauner A; Agrawal P; Salvatico J; Tapia T; Dhir V; Shaik SF; Drake DR; Byers AM
    Vaccine; 2017 Oct; 35(41):5487-5494. PubMed ID: 28413134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.
    Faenzi E; Zedda L; Bardelli M; Spensieri F; Borgogni E; Volpini G; Buricchi F; Pasini FL; Capecchi PL; Montanaro F; Belli R; Lattanzi M; Piccirella S; Montomoli E; Ahmed SS; Rappuoli R; Del Giudice G; Finco O; Castellino F; Galli G
    Vaccine; 2012 Jun; 30(27):4086-94. PubMed ID: 22521851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.
    Merani S; Kuchel GA; Kleppinger A; McElhaney JE
    Exp Gerontol; 2018 Jul; 107():116-125. PubMed ID: 28958701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.
    Tam YH; Valkenburg SA; Perera RAPM; Wong JHF; Fang VJ; Ng TWY; Kwong ASK; Tsui WWS; Ip DKM; Poon LLM; Chau CKV; Barr IG; Peiris JSM; Cowling BJ
    Clin Infect Dis; 2018 Mar; 66(6):904-912. PubMed ID: 29069368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine.
    Song JY; Cheong HJ; Noh JY; Seo YB; Choi WS; Cho GJ; Hwang TG; Kim WJ
    J Med Virol; 2013 Sep; 85(9):1591-7. PubMed ID: 23852684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.
    Wagner A; Garner-Spitzer E; Jasinska J; Kollaritsch H; Stiasny K; Kundi M; Wiedermann U
    Sci Rep; 2018 Jun; 8(1):9825. PubMed ID: 29959387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.